Roundview Capital LLC Amgen Inc Transaction History

Roundview Capital LLC

$1.35 Billion
Q3 2024

A detailed history of Roundview Capital LLC transactions in Amgen Inc stock. As of the latest transaction made, Roundview Capital LLC holds 900 shares of AMGN stock, worth $251,955. This represents 0.02% of its overall portfolio holdings.

Number of Shares

900

Previous 881 2.16%

Holding current value

$251,955

Previous $275,000 5.09%

% of portfolio

0.02%

Previous 0.02%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$309.38 - $337.38 $5,878 - $6,410	19 Added 2.16%	900 $289,000
Q1 2024 May 06, 2024	SELL	$268.87 - $324.56 $2,957 - $3,570	-11 Reduced 1.23%	881 $250,000
Q4 2023 Feb 12, 2024	SELL	$255.7 - $288.46 $112,508 - $126,922	-440 Reduced 33.03%	892 $256,000
Q3 2023 Nov 13, 2023	SELL	$218.65 - $271.46 $10,932 - $13,572	-50 Reduced 3.62%	1,332 $357,000
Q2 2023 Aug 09, 2023	SELL	$214.27 - $253.37 $12,641 - $14,948	-59 Reduced 4.09%	1,382 $306,000
Q1 2023 May 09, 2023	SELL	$225.79 - $275.2 $287,882 - $350,880	-1,275 Reduced 46.94%	1,441 $348,000
Q4 2022 Feb 13, 2023	SELL	$229.03 - $291.01 $178,414 - $226,696	-779 Reduced 22.29%	2,716 $713,000
Q3 2022 Nov 10, 2022	SELL	$224.46 - $253.15 $1.09 Million - $1.23 Million	-4,878 Reduced 58.26%	3,495 $788,000
Q2 2022 Aug 11, 2022	SELL	$230.71 - $256.74 $2,307 - $2,567	-10 Reduced 0.12%	8,373 $2.04 Million
Q1 2022 May 11, 2022	BUY	$219.27 - $242.57 $23,461 - $25,954	107 Added 1.29%	8,383 $2.03 Million
Q4 2021 Feb 10, 2022	SELL	$198.88 - $227.6 $27,445 - $31,408	-138 Reduced 1.64%	8,276 $1.86 Million
Q3 2021 Nov 10, 2021	SELL	$212.27 - $248.7 $14,009 - $16,414	-66 Reduced 0.78%	8,414 $1.79 Million
Q2 2021 Aug 10, 2021	BUY	$233.58 - $259.14 $114,921 - $127,496	492 Added 6.16%	8,480 $2.07 Million
Q4 2020 Feb 08, 2021	BUY	$216.38 - $257.67 $67,510 - $80,393	312 Added 4.06%	7,988 $1.84 Million
Q2 2020 Aug 13, 2020	BUY	$197.81 - $242.74 $14,044 - $17,234	71 Added 0.93%	7,676 $1.81 Million
Q1 2020 May 11, 2020	BUY	$182.24 - $241.7 $14,396 - $19,094	79 Added 1.05%	7,605 $1.54 Million
Q4 2019 Feb 10, 2020	BUY	$189.21 - $243.2 $3,784 - $4,864	20 Added 0.27%	7,526 $1.81 Million
Q3 2019 Nov 12, 2019	SELL	$174.11 - $208.62 $171,846 - $205,907	-987 Reduced 11.62%	7,506 $1.45 Million
Q2 2019 Aug 12, 2019	BUY	$166.7 - $195.41 $477,595 - $559,849	2,865 Added 50.91%	8,493 $1.57 Million
Q1 2019 May 09, 2019	BUY	$180.87 - $203.88 $40,334 - $45,465	223 Added 4.13%	5,628 $1.07 Million
Q4 2018 Feb 13, 2019	BUY	$178.4 - $208.25 $99,190 - $115,787	556 Added 11.47%	5,405 $1.05 Million
Q3 2018 Nov 07, 2018	BUY	$185.29 - $208.89 $69,483 - $78,333	375 Added 8.38%	4,849 $1.01 Million
Q2 2018 Aug 10, 2018	BUY	$166.05 - $186.51 $229,149 - $257,383	1,380 Added 44.6%	4,474 $826,000
Q1 2018 May 14, 2018	SELL	$169.43 - $198.0 $576,570 - $673,794	-3,403 Reduced 52.38%	3,094 $527,000
Q3 2017 Nov 13, 2017	BUY	$167.29 - $191.0 $1.09 Million - $1.24 Million	6,497	6,497 $1.12 Million

Others Institutions Holding AMGN

# of Institutions

3,120

Shares Held

410M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $150B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Roundview Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Roundview Capital LLC with notifications on news.

Account

Roundview Capital LLC Amgen Inc Transaction History